The 20 Best Guillain-Barre Syndrome Doctors Near Me in Ann Arbor, MI

Zach London, M.D. is a Professor in the University of Michigan Medical School. Dr. London grew up in Milwaukee, Wisconsin. He graduated Magna Cum Laude from Brown University in 1997. He attended medical school at the University of Wisconsin – Madison, graduating in 2001. He completed a Preliminary Medicine Internship at St. Joseph Mercy Hospital in Ann Arbor in 2001, followed by Neurology Residency at the University of Michigan. After graduation from residency, he did a one-year fellowship in Clinical Neurophysiology/EMG at the University of Michigan.He joined the University of Michigan faculty as a neuromuscular neurologist in 2006, and has served as Program Director of the neurology residency program. Dr. London’s scholarly focus is the development of interactive educational tools, with a focus on educational boardgames. He is the founder of Neurd Games, which includes popular titles such as The Lesion: Charcot’s Tournament, The Plexus, Endowed Chairs: Neurology, Formaina, and Field Cut. He also created EMG Whiz, a popular web-based EMG training simulator, and mobile applications to teach the tenets of neuroanatomic localization.He has published online learning modules for the American Academy of Neurology and other national organizations, in addition to traditional publishing research regarding medical education and electrodiagnostic studies.Dr. London has been recognized with numerous national teaching awards, including the American Academy of Neurology (AAN) A.B. Baker Lifetime Achievement Award in Neurologic Education in 2023, The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Innovation Award in 2021, and the American Neurological Association (ANA) Distinguished Teacher Award in 2017. At the University of Michigan, he received the 2013 Silver Shovel Award, the Provost’s Teaching Innovation Prize in 2015, and, in 2017, the Kaiser Permanente Award. Departmental honors include the Status Pedagogicus Award in 2008, and the James Albers Collegiate Professorship in 2018. He has been an honorary member of the GALENS medical society most years since 2011. Dr. London regularly speaks at national meetings on topics of medical education, game development, and clinical neurophysiology. He has served as chair or member of committees and workgroups for the AAN, ANA, AANEM, and ACGME, including serving as the Chair of the Consortium of Neurology Program Directors.Outside his work, Zach London is a founding board member of the Penny Seats Theatre Company in Ann Arbor. He has also composed and released one original song every month since 1993, posting them on his personal website www.hardtaco.org. Dr. London is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Chronic Polyradiculoneuritis. Dr. London is board certified in Neuromuscular Medicine, Neurology, and Electrodiagnostic Medicine.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

Dr. Sieloff received his bachelor's degree in Biomedical Engineering at the University of Michigan. He then completed both medical school, 2013, and residency, 2017, at University of Michigan, serving as chief neurology resident during his final year of residency. As faculty, he works as a neuro-hospitalist and tele-neurologist, in addition to caring for patients in both the general and multiple sclerosis neurology clinics. Dr. Sieloff is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Generalized Tonic-Clonic Seizure, Seizures, Conversion Disorder, Chronic Polyradiculoneuritis, and Gastrostomy. Dr. Sieloff is board certified in Neurology.

Dr. Venkatakrishna Rajajee completed his medical training at the Madras Medical College in India. He completed his residency in Neurology at the Mount Sinai Medical Center, New York in 2003, followed by fellowships in Stroke/ Vascular Neurology and Neurological Critical Care at the UCLA Medical Center 2003-2005. In addition, he has several years of experience in private practice as an attending physician in medical/ surgical intensive care units. He joined the University of Michigan’s neurosurgery department 2008 as faculty neurointensivist and vascular neurologist. He has served as the medical director of neurocritical care since 2014 and as co-director of the comprehensive stroke center since 2017.Dr. Rajajee has had a clinical, educational, and research interest in critical care ultrasound since 2007. He is a diplomate of the National Board of Echocardiography. He has published several articles on optic nerve ultrasound and transcranial doppler in neurocritical care, and helped pioneer the use of real-time ultrasound guidance during bedside tracheostomy in 2011. Dr. Rajajee developed and directed the Neurocritical Care Society’s (NCS) annual critical care ultrasound workshop between 2012-2014, and has served on the Society of Critical Care Medicine’s (SCCM) Ultrasound Committee. He currently coordinates the University of Michigan’s multidisciplinary critical care ultrasound lecture series.His other interests include the monitoring and management of patients with severe Traumatic Brain Injury (TBI). In 2013, Michigan Medicine signed a memorandum of understanding on collaboration in research and education with the All India Institute of Medical Sciences (AIIMS), New Delhi, with TBI as a major focus. As part of this collaboration, Dr. Rajajee has received funding from the National Institutes of Health (NIH) to study techniques of intracranial pressure assessment applicable to low and middle income nations. He has also received funding from the Department of Defense (DoD) to evaluate noninvasive techniques to assess the brain following TBI.He is a former chair of the Neurocritical Care Society’s Guidelines Committee, and the GRADE methodologist of the NCS guidelines for neuroprognostication in neurocritical care. He is the first author of the 2023 Guidelines for Neuroprognostication in Comatose Adult Survivors of Cardiac Arrest. Dr. Rajajee is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Brain Herniation, Chiari Malformation Type 1, Chiari Malformation, Gastrostomy, and Transmyocardial Revascularization.

Dr. Brian M. Kelly is a Professor in the Department of Physical Medicine and Rehabilitation (PMR) at the University of Michigan Medical School and Medical Director for the Division of Orthotics and Prosthetics of the Department of Physical Medicine and Rehabilitation Services at the University of Michigan. Prior to joining the faculty of the University of Michigan in 2002, Dr. Kelly worked in Chicago after graduation from residency. Dr. Kelly has been caring for people that suffer from amputations, trauma, spinal cord injuries, strokes, and traumatic brain injuries for 15 years. He has gained national recognition for his work, lecturing across the country at national meetings on gait evaluation and disorders, amputation, prosthetics, and neurologic disorders. Throughout his career, Dr. Kelly has published numerous articles and chapters on prosthetics and orthotics. In 2014, Dr. Kelly published Prosthetic Restoration of the Upper and Lower Extremity, a new textbook on prosthetic restoration, with his University of Michigan colleagues that reflects their vast clinical experience and teaching skills related to prosthetics. Dr. Kelly has devoted a significant amount of time and energy to the education, training and evaluation of resident physicians. He has been honored with the highest teaching awards available at all of the institutions that he has served. Dr. Kelly is the vice-chair and chair-elect to the National Board of Osteopathic Medical Examiners. He produces examination materials in an effort to demonstrate the resident’s competence on their national board examinations for board certification. Dr. Kelly graduated Cum Laude in 1991 from Aquinas College in Grand Rapids, Michigan. He received his medical degree from Michigan State University in East Lansing, Michigan and completed his residency training at Rush-Presbyterian Medical Center in Chicago, Illinois. Dr. Kelly is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Phantom Limb Pain, Stroke, Guillain-Barre Syndrome, and Miller-Fisher Syndrome. Dr. Kelly is board certified in Physical Medicine & Rehab.

Gary Gallagher, MD completed his undergraduate bachelor of science degree in Industrial and Operations Engineering at the University of Michigan. An interest in health sciences, lead him to attend medical school at Wayne State University of Medicine in Detroit, MI where he received his doctorate of medicine in 2008. He completed residency in neurology and fellowship in neuromuscular medicine at the University of Michigan. During final year of residency, he served as chief resident. Following completion of fellowship, Dr. Gallagher joined the neurology faculty at the University of Michigan.Dr. Gallagher is interested in the clinical care of neuromuscular disease, tele-medicine, electrodiagnostic procedures (EMG and intraoperative monitoring). His clinical time is spent in the outpatient neuromuscular clinic providing longitudinal care for patients and on the inpatient service caring for acute neurologic problems including stroke management, epilepsy, neuromuscular crisis and auto-immune neurologic disease. In addition, he has strong interest in medical trainee education and he serves as the neuromuscular fellowship director at the University of Michigan. Finally, Dr. Gallagher has strong interest in patient safety and quality improvement and oversees departmental efforts to improve. Dr. Gallagher is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 71 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Multifocal Motor Neuropathy, Inclusion Body Myositis, and Peripheral Neuropathy.

Dr. Rodriguez is Medical Director of the Wheelchair Seating Clinic and PM&R Administrator in the Michigan Bowel Control Clinic and the Wound Care Clinic. She has been actively involved in research with the Spinal Cord Injury Model System. She has written and collaborated on several research publications and written chapters on SCI sequelae in premier journals and textbooks in PM&R. Dr. Rodriguez has been recognized for her teaching of trainees with the Silver Crutch award. She is the associate SCI fellowship program director. She also serves on the International Standards and Autonomic Standards Committees, two crucial committees of the American Spinal Injury Association that are responsible for development of any new standards documents related to SCI, continuous review and improvement of the existing ASIA documents on neurological and autonomic standards and development and oversight of the International Data Sets project. Dr. Rodriguez is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 43 other conditions, according to our data. Her clinical expertise encompasses Neurogenic Bowel, Paraplegia, Spasticity, and Autonomic Dysreflexia.

Dr. Pangilinan is the medical student clerkship director for PM&R. His clinical practice is in neurorehabilitation, including staffing the in-patient rehabilitation unit, and staffing the TBI/Polytrauma out-patient clinic in the VA-Ann Arbor. He is a consultant at the Heartland of Ann Arbor subacute service. As clerkship director, he works with 4th year medical students, and is the PM&R faculty advisor for students interested in PM&R residency programs. He was involved in the planning of the new medical student curriculum. As part of that effort, he will be a teaching faculty/coach for a group of students in one of four “M-Homes,” which are designed to give the student a “home base” for mentoring and learning. He is a member of the Admission Committee/ Admissions Executive Committee. His current research has involved investigating diagnostic and prognostic factors in veterans with TBI. Dr. Pangilinan is a member of the AAP’s education committee and also serves as the president of the AAP’s Medical Student Educators Council. Dr. Pangilinan is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Stroke, Hemiplegia, Concussion, and Subarachnoid Hemorrhage. Dr. Pangilinan is board certified in Physical Medicine & Rehab and Brain Injury Medicine.

Maryam Berri MD, is a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation at the University of Michigan Medical School.Clinical work includes concomitant traumatic brain and spinal cord injury, myelomeningocele, cerebral palsy, and neurogenic bowel disease treatment. She is pursuing research in lactational outcomes and management for those with neurological disease. She has a strong interest in medical education as well as education and optimization in practice management for faculty. She serves as the revenue physician lead for the department. She is an active in the rehabilitation Standards Committee with the American Spinal Injury Association.Dr. Berri received her BS degree from the University of Michigan in 2009, and then in 2013, she graduated from the American University of the Caribbean in Pembroke Pines, FL. She then completed her residency in Physical Medicine and Rehabilitation at Wayne State University followed by subspecialty fellowship in Spinal Cord Injury at the University of Michigan. Dr. Berri is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Autonomic Dysreflexia, Brown-Sequard Syndrome, Spasticity, and Neurogenic Bowel. Dr. Berri is board certified in Physical Medicine & Rehab, Spinal Cord Injury Medicine, and Brain Injury Medicine.

Dr. Sean Smith is the Medical Director of Michigan Medicine's Cancer Rehabilitation program, with a clinical emphasis on restoring function and reducing symptom burden in patients with a history of cancer. In addition to chairing the AAPM&R's Cancer Rehabilitation Physician Consortium and the multi-site research collaborative, the Cancer Rehabilitation Metrics Consortium, he serves on the editorial board of the Journal of Clinical Oncology, and is a Deputy Associate Editor for Supportive Care in Cancer. He has published numerous peer-reviewed manuscripts and has conducted educational seminars on cancer rehabilitation on three continents. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Foot Drop, Lymphedema, and Femoral Nerve Dysfunction. Dr. Smith is board certified in Physical Medicine & Rehab.

Michael M. Wang, M.D. Ph.D., is an assistant professor of neurology and director of molecular stroke research in the Department of Neurology at the University of Michigan. He also is an assistant professor of molecular and integrative physiology at the U-M and a physician in neurology at the VA Ann Arbor Healthcare System.Dr. Wang's research includes laboratory investigations into the molecular basis of stroke and the interaction between stroke, circadian rhythms and disordered sleep. A major interest of the lab is investigating the causes and treatment of CADASIL (Cerebral Autosomal Dominant Arteriopathy Subcortical Infarcts and Leukoencephalopathy), a devastating inherited cause of stroke and vascular dementia. His other interests include studies of the functions of endogenous hormones (estrogen) and differentiation factors on neurons.He received his bachelor's degree, summa cum laude, from Harvard University and earned his medical degree and doctorate in molecular biology and genetics from Johns Hopkins University (JHU) in 1994. In 1998, he completed his neurology residency at JHU; in 2000, he completed a stroke research fellowship with Drs. Richard Traystman and Patricia Hurn. Dr. Wang spent three years on the neurology faculty at JHU before joining the U-M faculty in 2003. During his time at JHU, he also served as a staff neurologist at the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center, both in Baltimore, Maryland.Dr. Wang was elected to Phi Beta Kappa during his junior year at Harvard and to Alpha Omega Alpha at JHU. While a fellow, he was awarded funding from the National Stroke Association and the American Heart Association, and also received a Burroughs Wellcome Career Award in Biomedical Sciences. His research has been supported by the National Institutes of Health (NIH) since 2001.He has published his scientific work in Nature, Journal of Neuroscience and Stroke, and has served as a member of national grant review committees of the NIH and the American Heart Association. His bibliography includes more than 20 peer-reviewed publications, seven book chapters, and numerous abstracts and clinical papers. He also is an ad hoc reviewer for the Journal of Cerebral Blood Flow and Metabolism, American Journal of Physiology, Stroke, and Neurology, among others.At the U-M, Dr. Wang is involved in medical student pre-clinical education, resident education and clinical studies conducted by the U-M Brain Injury Group. He is a member of the Stroke Council of the American Heart Association and a member of the Society of Neuroscience. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Vascular Dementia, Stroke, Stent Placement, and Transmyocardial Revascularization. Dr. Wang is board certified in Vascular Neurology and Neurology.

Mollie McDermott, MD, MS, is an assistant professor in the Department of Neurology. She completed subspecialty training in Vascular Neurology. She received her bachelor’s degree from Mount Holyoke College and her medical degree from Dartmouth Medical School. Dr. McDermott completed her residency training in Neurology at the University of Michigan, where she served as chief resident from 2014 to 2015. In 2017 she received her master of science degree in clinical research design and statistical analysis from the University of Michigan.Dr. McDermott is interested in acute stroke management, secondary stroke prevention, cardioembolic stroke, and atypical causes of stroke. She is the director of the Telestroke Program and the medical director of the Comprehensive Stroke Center. Dr. Mcdermott is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Stroke, Dysarthria, Cerebral Amyloid Angiopathy, Stent Placement, and Transmyocardial Revascularization. Dr. Mcdermott is board certified in Neurology and Vascular Neurology.

Dawn Kleindorfer is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Kleindorfer is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Spasticity, Embolectomy, and Thrombectomy. Dr. Kleindorfer is board certified in Neurology and Vascular Neurology.

Garrett Conyers graduated Phi Beta Kappa and with honors from Morehouse College. He received his MD from Harvard Medical School during which time he also completed a Masters in Public Policy from the Harvard Kennedy School of Government. He took two years off in medical school to lead a community participatory research project looking into health inequities in underserved communities in Boston. Dr. Conyers then completed a neurology residency at the Johns Hopkins Hospital followed by a fellowship in vascular neurology at the University of Michigan. Clinically, he has a special interest in moyamoya disease and shared decision making. He is involved in several diversity, equity and inclusion committees nationally. He is passionate about healthcare equity and optimizing systems of care for vulnerable populations, such as imprisoned and socioeconomically disadvantages patients. Dr. Conyers is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stroke, Moyamoya Disease, Dysarthria, Thrombectomy, and Transmyocardial Revascularization. Dr. Conyers is board certified in Neurology.

Ava Lin is a Neuromusculoskeletal Medicine specialist and a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Familial Dysautonomia, Hereditary Sensory Neuropathy Type 1 (HSN1), and Andermann Syndrome. Dr. Lin is board certified in Neurology W/Spec Qual Child Neuro and Neuromuscular Medicine.

Alecia K Daunter MD is an Associate Professor of Physical Medicine and Rehabilitation. She completed her medical degree, residency, and fellowship training at the University of Michigan. She is board certified in Physical Medicine and Rehabilitation. She joined the Michigan Medicine faculty in 2018.Dr. Daunter's research interests include function and quality of life outcomes in patients with developmental disabilities or pediatric onset medical conditions. Dr. Daunter is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, Spinal Muscular Atrophy with Arthrogryposis, and Rhizotomy. Dr. Daunter is board certified in Pediatric Rehabilitation Medicine and Physical Medicine & Rehab.

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Knierbein is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 125 other conditions, according to our data. Her clinical expertise encompasses Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Knierbein is board certified in Neurology W/Spec Qual Child Neuro and Neuromuscular Medicine.

Nicole Pariseau is a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Pariseau is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 122 other conditions, according to our data. Her clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Conversion Disorder, and Memory Loss. Dr. Pariseau is board certified in Neurology W/Spec Qual Child Neuro.

Alan D. Salgado, M.D. is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Salgado grew up in Gainesville, Florida. He graduated Summa Cum Laude from the University of Florida in 2011. Prior to attending medical school, he completed a postbaccalaureate research training fellowship at the National Institutes of Health. In 2016 he graduated from the University of Florida College of Medicine. He completed a preliminary medicine internship at MedStar Georgetown University Hospital, followed by neurology residency at Vanderbilt University Medical Center. He further completed a fellowship in neuromuscular medicine and EMG at Duke University Medical Center.Dr. Salgado joined the neurology faculty at the University of Michigan in 2022. Dr. Salgado is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy Type 3, Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Thrombectomy. Dr. Salgado is board certified in Neurology, Neuromuscular Medicine, and Electrodiagnostic Medicine.